PROINNATC Numbing Cream

Manufacturer
Guangzhou Haishi Biological Technology Co., Ltd.
Effective date
2025-07-16
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:07:31

Label at a glance#

ProductPROINNATE Numbing Cream
Active ingredientMENTHOL
Label structure11 sections

Indications and uses

1, Clean your hands and treatment area thoroughly with mild soap and warm water. Dry them afterward. 2, Apply a thick layer of numbing cream to the treatment area, making sure to cover both the tattooed area and its surroundings. 3, Wrap the area securely with plastic wrap and leave it on for 40-60 minutes for the best results (keeping it on longer gives better effects). 4, Remove any remaining cream and wait an a...

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Menthol 10%

Purpose

OTC - PURPOSE SECTION

For the temporary alleviation of localized skin paindiscomfort, pruritus, or burning sensation.

Uses

INDICATIONS & USAGE SECTION

1, Clean your hands and treatment area thoroughly with mild soap and warm water. Dry them afterward.
2, Apply a thick layer of numbing cream to the treatment area, making sure to cover both the tattooed area and its surroundings.
3, Wrap the area securely with plastic wrap and leave it on for 40-60 minutes for the best results (keeping it on longer gives better effects).
4, Remove any remaining cream and wait an additional 5 minutes for the numbing sensation to reach its peak.

Warnings

WARNINGS SECTION

For external use only.

Stop use and ask a doctor if

OTC - STOP USE SECTION

rash occurs.

Do not use

OTC - DO NOT USE SECTION

if you are allergic to the ingredients in this product or ifthe seal is broken or missing.

When using this product

OTC - WHEN USING SECTION

keep out of eyes. Rinse with water to remove.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

3. Children under 2 vears: Do not use

If swallowed, get medical help or contact a Poison Control Center right away.

Dosage

DOSAGE & ADMINISTRATION SECTION

Apply to affected area not more than 3 times daily.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aqua 69%

Mentha Arvensis Leaf Extract, 3%
Zanthoxylum Bungeanum Fruit Extract, 5%
Arnica Montana, 3%
Emu Oil, 2%
Chrysanthellum Indicum Extract, 1%
Propylene Glycol, 5%
Disodium Edta, 1%
Portulaca Oleracea Extract, 1%

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
253020menthol 10 % Topical CreamPSN2
253020menthol 100 MG/ML Topical CreamSCD2
253020menthol 10 % Topical CreamSY2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60771-0024-1PROINNATE Numbing Cream120 g in 1 BOTTLECREAM1202

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60771-002460771-0024-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
ARNICA MONTANAO80TY208ZWIACT
EMU OIL344821WD61IACT
MENTHOLL7T10EIP3AACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PROINNATE Numbing CreamMENTHOLGuangzhou Haishi Biological Technology Co., Ltd.39688b2b-c1fe-cd86-e063-6394a90a53452025-07-16WarningsExact identifier
ndc (package): 60771-0024-1
ndc (product): 60771-0024
ndc11 (package): 60771002401
spl id: 3a179574-9e57-fdcd-e063-6394a90a2b92
spl set id: 39688b2b-c1fe-cd86-e063-6394a90a5345

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.